Humacyte, Inc.

HUMA

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001818382

SEC filings (opens in a new tab)

In the last 90 days, Humacyte, Inc. insiders filed 3 open-market purchases and 0 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $57.3M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Humacyte, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of HUMA: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	95	1	123	+29
Shares	23.3M	23.3K	31.2M	+7.95M (+34.2%)
Value	$72.4M	$70.2K	$149.8M	+$77.5M (+107.1%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (46)

Institutions that held Humacyte, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to HUMA in Q2 2024
Institution	Shares	Value	% of portfolio
Voloridge Investment Management, LLC	687,296	$3.30M	0.01%
Deerfield Management Company, L.P. (Series C)	322,851	$1.55M	0.03%
Two Sigma Advisers, LP	264,300	$1.27M	0.00%
Jump Financial, LLC	160,297	$769.4K	0.02%
Prudential Financial Inc	157,305	$755.1K	0.00%
ARS Investment Partners, LLC	116,419	$558.8K	0.05%
Rafferty Asset Management, LLC	104,296	$500.6K	0.00%
Bank of Montreal	98,601	$495.0K	0.00%
Engineers Gate Manager LP	100,560	$482.7K	0.01%
Corebridge Financial, Inc.	47,291	$227.0K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	34,840	$166.8K	0.00%
Alpine Global Management, LLC	26,744	$128.4K	0.02%
Dynamic Technology Lab Private Ltd	24,734	$119.0K	0.01%
XTX Topco Ltd	22,877	$109.8K	0.01%
David J Yvars Group	22,750	$109.2K	0.07%
Profund Advisors LLC	20,271	$97.3K	0.00%
Omers Administration Corp	19,600	$94.1K	0.00%
Brevan Howard Capital Management LP	18,890	$90.7K	0.01%
Principal Financial Group Inc	17,196	$82.5K	0.00%
Verition Fund Management LLC	16,139	$77.5K	0.00%
Regions Financial Corp	12,173	$58.4K	0.00%
Tudor Investment Corp Et Al	12,151	$58.3K	0.00%
Jones Financial Companies LLLP	11,166	$53.6K	0.00%
Cambridge Investment Research Advisors, Inc.	11,027	$53.0K	0.00%
Beacon Pointe Advisors, LLC	10,000	$48.0K	0.00%
nVerses Capital, LLC	5,900	$28.3K	0.02%
Mirae Asset Global Investments Co., Ltd.	3,555	$16.7K	0.00%
CWM, LLC	2,773	$13.0K	0.00%
CIBC Private Wealth Group, LLC	2,000	$11.3K	0.00%
Hollencrest Capital Management	2,000	$9.60K	0.00%
Principal Securities, Inc.	1,000	$4.80K	0.00%
Proequities, Inc.	1,000	$4.80K	0.00%
Eukles Asset Management	1,000	$4.80K	0.00%
SRS Capital Advisors, Inc.	783	$3.76K	0.00%
Pacer Advisors, Inc.	593	$2.85K	0.00%
Fifth Third Bancorp	500	$2.40K	0.00%
Wolff Wiese Magana LLC	500	$2.40K	0.00%
Russell Investments Group, Ltd.	378	$1.81K	0.00%
Bare Financial Services, Inc	104	$984	0.00%
IFP Advisors, Inc	200	$960	0.00%
Hexagon Capital Partners LLC	200	$960	0.00%
Spectrum Wealth Counsel, LLC	200	$960	0.00%
HM Payson & Co	100	$480	0.00%
Rothschild Investment LLC	65	$312	0.00%
Burkett Financial Services, LLC	18	$86	0.00%
ORG Partners LLC	5	$26	0.00%

Sold out (17)

Institutions that held Humacyte, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of HUMA in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
AIGH Capital Management LLC	2,155,958	$6.71M
Sio Capital Management, LLC	2,000,000	$6.22M
Prescott General Partners LLC	568,246	$1.77M
Capstone Investment Advisors, LLC	312,400	$971.6K
Lion Point Capital, LP	235,000	$730.9K
DG Capital Management, LLC	230,238	$716.0K
Clough Capital Partners L P	156,263	$486.0K
Shay Capital LLC	59,858	$186.2K
Seven Grand Managers, LLC	50,000	$155.5K
American International Group, Inc.	30,180	$93.9K
Hartline Investment Corp	22,450	$69.8K
Oxford Asset Management LLP	20,374	$63.4K
State of Wisconsin Investment Board	16,700	$51.9K
Wolverine Asset Management LLC	1,715	$5.33K
Metropolitan Life Insurance Co	1,483	$4.61K
Comerica Bank	1,051	$3.27K
First Command Advisory Services, Inc.	150	$467

Not filed for Q2 2024 yet (1)

Institutions that held Humacyte, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HUMA in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Imprint Wealth LLC	23,321	$70.2K